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ABSTRACT 
Objective: Terminalia chebula fruits are used as traditional herbal medicine from the ancient era but still now, the extract has not revealed any 
research data on CNS depression activity as well as its lyophilized herbal formulation. The present study was designed to evaluate CNS depression 
activity and develop lyophilized oral cake of Terminalia chebula fruit extract. 
Methods: CNS depression potential of Terminalia chebula fruit was examined using the hole board, hole cross, and thiopental sodium induced 
sleeping time test. The human equivalent dose was calculated based on US FDA guidelines of dose conversion between animals and humans. A novel 
lyophilized herbal oral cake of aqueous extract of Terminalia chebula fruits with additives was then formulated. The formulated cake was subjected 
to characterize its physicochemical properties such as appearance, residual humidity, drug content, dissolution, and drug release profile, extract-
polymer compatibility by Fourier-transform infrared spectroscopy (FTIR) and stability. The prepared cake was further evaluated with the hole 
board and hole cross model in mice and compared with control to ensure its CNS depression activity. 
Results: Crude extract at the doses of 100, 150, 200, and 400 mg/kg body weight showed significant (p<0.01) dose-dependent inhibition of 
locomotor behavior. Crude extract dose of 200 mg/kg body weight in mice compared with standard diazepam dose (1 mg/kg) was used to calculate 
the human equivalent dose of 1000 mg/60 kg. The formulation presented a rapid drug release profile while drug content was approximately 99.5%. 
FTIR spectroscopy of formulation showed no drug-excipient interaction. The oral cake at the dose of 200 mg/kg body weight showed significant 
(p<0.01) CNS depression activity.  
Conclusion: CNS depression activity, FTIR, and stability analysis ensure the preservation of active ingredients in the lyophilized oral cake as in the 
crude extract. 
Keywords: Terminalia chebula, Lyophilized herbal formulation, Fourier-transform infrared spectroscopy (FTIR), Locomotors movement 
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INTRODUCTION 
Plants provide humankind with new remedies when fulfilling the 
fundamental needs like food and shelter. Thus plants have 
fabricated the premise of sophisticated traditional systems of 
medicine for thousands of years [1]. Traditional medicine is used 
everywhere in the world and its economic importance is growing 
fast, mainly because the use of medicinal plants has gained a 
respectable position today, especially in developing countries [2]. 
About 60-85% of the population in developing countries has to rely 
on traditional medicine [3]. Traditional medicine is practiced widely 
in China, India, Japan, Pakistan, Sri Lanka, Thailand, and Korea [4]. 
Terminalia chebula (TC) Retz (Combretaceae) is one of the most 
revered medicinal plants in the Indian subcontinent.  
Tibetans, ayurvedic apothecaries, and other folk medicinal 
practitioners consider the fruit of Terminalia chebula as the "king of 
medicines" [5]. The fruit of the tree exhibits diverse health benefits 
and has been used as traditional medicine for a household remedy 
against various human ailments since antiquity [6].  
It is reported that depression and anxiety disorders are the most 
familiar mental illness in humans. It is life-threatening and causes a 
greater decrement in health state than major chronic physical 
illnesses such as angina, arthritis, asthma, and diabetes [7]. These 
disorders incur a huge economic and social cost to depressed 
people. Nowadays, there seems to be overdependence on synthetic 
drugs for alleviating certain emotional disorders. Meanwhile, 
researches have exposed that many people look for herbal products 
for the treatment of different kinds of psychiatric disorders [8]. 
As the global scenario is now changing towards the use of non-toxic 
edible plant products having traditional medicinal use, we 
developed oral lyophilized cake of aqueous extract of Terminalia 
chebula (AETC) fruits. The oral lyophilized cake is prepared by 
enclosing a drug and suitable additives in a water-soluble matrix. 
Because of the high porosity, oral lyophilized cake disintegrates 
faster than other systems providing the advantage of rapid onset of 
action and patient compliance [9]. 
So far, there is no report demonstrating the sedative-hypnotic 
activity of Terminalia chebula fruits. As a result, we aimed to 
evaluate the CNS depression activity of this fruit extract on mice. At 
the same time, we formulated and characterized a novel lyophilized 
herbal oral cake of AETC fruits for CNS depression. 
MATERIALS AND METHODS 
Chemicals 
Mannitol, sorbitol, lactose, aspartame used in the investigation were 
obtained from Merck KGaA (Darmstadt, Germany) and the dialysis 
membrane was purchased from Spectrum Medical Industries Inc, 
(60916 Terminal Annex, Los Angeles, US). The standard drug 
diazepam and thiopental sodium were purchased from Square 
Pharmaceuticals Ltd, Bangladesh, and Advanced Chemical Industries 
Ltd, Bangladesh, respectively. 
Experimental animal 
In the present study, young Swiss-albino mice of average 20-30 g 
aged 4-5 w were used. They were kept at an ambient temperature of 
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25±1 °C, the relative humidity of 55-65% with 12 h light: 12 h dark 
cycle in the animal house of Pharmacy Discipline, Khulna University, 
Bangladesh. The animals were purchased from the International 
Centre for Diarrheal Disease Research, Bangladesh (ICDDR’B), and 
acclimatized to laboratory conditions for one week prior to the 
experiment. The experimental protocol was approved by the Animal 
Ethics Committee, Life Science School, Khulna University, 
Bangladesh (Approval number: KU/PHARM/AEC/15/006/023). 
Extraction and preparation of test sample 
Terminalia chebula (Retz.) fruits were collected from the local area of 
Khulna district, Bangladesh in January 2017 in the daytime. The 
collected fruits were dried by shade drying for 15-20 d. The separated 
peels were crushed into fine particles and placed into Soxhlet extractor. 
Distilled water (heated to reflux) passed through the main chamber and 
the partially soluble components were slowly transferred to the solvent 
(Soxhlet extraction-Royal Society of Chemistry). Then the liquid solvent 
was filtered by using the Whatman filter paper. Finally, the filtrate was 
allowed to freeze at-20 C and lyophilized at-54 ᵒC with<100mTorrin 
(Labconco Lyophilizer, China) and then fully dried with a secondary 
drying process with increasing temperature up to 35 °C. The total yield 
of the freeze-dried extract was 4.62% (w/w). 
Hole board test of crude extract 
The hole board test was conducted following the methods of 
Anisuzzman et al. 2017[10]. Mice were divided into 6 groups and 
each group comprised of 5 mice with 20-30 g in weight. Group I was 
administered 1% tween-80 orally at 10 ml/kg, Group II (standard) 
was treated with diazepam at 1 mg/kg body weight dose as an oral 
suspension and Group III, ІV, V, and VI termed as test groups were 
given AETC fruits orally at the doses of 100, 150, 200, and 400 
mg/kg body weight respectively. At the beginning of the test, the 
mouse was placed on the edge of the board. The number of head 
dipping into the holes was counted as the measurement for 3 min on 
0, 30, 60, 90, 120, and 150 min entire the observation period. The 
experiment was carried out in a sound-attenuated room. 
Hole cross test of crude extract  
Mice were divided into 6 groups and each group comprised of 5 
mice. Group I was given 1% tween-80 orally at 10 ml/kg, Group II 
(standard) was treated with diazepam at 1 mg/kg bodyweight oral 
dose and Group III, ІV, V, and VI termed as test groups were given 
AETC fruits at the oral doses of 100, 150, 200, and 400 mg/kg body 
weight respectively. Then mice were placed individually in the 
darker chamber of the box segregated by a wall with a hole into dark 
and white chambers. The total number of crosses through the hole 
from one chamber to another by the mouse of each group within 3 
min was counted on 0, 30, 60, 90, 120, and 150 min. The experiment 
was conducted in a sound-attenuated room [11]. 
Thiopental sodium-induced sleeping time test of crude extract 
In this experiment, 30 experimental laboratory mice were arbitrarily 
chosen and accurately weighed. The mice were divided into six 
groups termed as a negative control group, positive control 
(standard) group and test groups (I, II, III, and IV). Five mice in each 
group were kept in six cages separately. Each mouse of the negative 
control group received orally 1% Tween-80 in distilled water at the 
dose of 10 ml/kg body weight. The mice of the positive control 
group received standard drug diazepam at the dose of 1 mg/kg body 
weight and each test group received crude extract at the dose of 100, 
150, 200, and 400 mg/kg body weight respectively. All doses were 
given orally with the help of a feeding needle. After 30 min, 
thiopental sodium (40 mg/kg) was given intraperitoneally to all 
groups for inducing sleep. The onset time of sleep was noted for all 
the animals. After induction of sleep, mice were placed in the 
inverted position and when sedation was over, the mice came to 
normal posture, and time was noted. The interval between loss and 
recovery of the righting reflex was used as an index of the hypnotic 
effect. The time interval between the injection of thiopental sodium 
and the start of sleep was recorded as latency time [12]. 
Acute toxicity test 
The mice were kept in a fasting condition for 16 h. Then 
experimental mice were divided into 6 groups of 5 mice per group. 
After that, the aqueous extract was administered orally at the dose 
of 800, 1000, 1500, 2000, and 3000 mg/kg body weight in each of 5 
groups, while the control group received distilled water. The 
animals were observed 72 h for measurement of mortality. General 
signs and allergic symptoms of toxicity were noted for each group 
according to the Organization for Economic Co-operation and 
Development (OECD) guide with slight modification [13, 14]. 
Human equivalent dose calculation based on body surface area 
The dose is equally related to bodyweight although it is not the lone 
factor that influences the scaling for dose calculation. The correction 
factor (Km) is estimated by dividing the average body weight (kg) of 
species to its body surface area (m2). The Km factor value of various 
animal species is used to estimate the Human Equivalent Dose 
(HED) as:  
HED in mg/kg =  Animal Dose (mg/kg)  
×  (Animal Km/Human Km) 
If the human body weighs 60 kg and the human body surface area 
approximates 1.6 m2, Km is 37 and for typical adult mice, Km value is 
3. An animal dose of 200 mg/kg body weight produced promising 
CNS depression effect comparable with that of standard diazepam. 
Taking the animal dose of 200 mg/kg body weight into 
consideration, we calculated the human equivalent dose [15]. 
Lyophilized formulation development 
Various quantities (table 1) of mannitol, sorbitol, lactose, and 
aspartame were dissolved in 5 ml distilled water and stirred with a 
magnetic stirrer until a clear solution was obtained. To formulate 
oral lyophilized cake, 1000 mg of aqueous extract (10% w/v) was 
dispersed in the excipient mixture and 10 ml volume was adjusted 
with distilled water. The resulting preparation was poured into vials. 
 
Table 1: An oral lyophilized cake of different formulation 




 AETC fruits (% w/v) 10 10 10 10 
Mannitol (% w/v) 3 4 5 6 
Sorbitol (% w/v) 5 4 3 2 
Binder Lactose (% w/v) 2 2 2 2 
Sweetener 
Solvent 
Aspartame (% w/v) 0.1 0.1 0.1 0.1 
Water (distilled) up to 10 ml 10 ml 10 ml 10 ml 10 ml 
The vials were then transferred to a freeze dryer (Lyofast 3, Italy) and the lyophilization was carried out according to the parameters that are 
presented in table 2. Then vials were sealed with inert nitrogen gas [16]. 
 
Table 2: Parameters of the lyophilization cycle 
Parameters Temperature ( °C) Hold for (min) Pressure (µ bar) 
Freezing step -45 540 -- 
Primary drying step -10 960 250 
Secondary drying step +15 360 200 
Appearance and residual humidity analysis 
Formulated herbal cakes were inspected visually and also analyzed 
for residual humidity by Karl Fisher titration using methanol as 
sample solvent [17]. 
The drug content in the oral lyophilized cake
The concentration of AETC fruits was determined 
spectrophotometrically from the calibration graph using the 
equation, x = (y − c)/m. Where, y = Absorbance, x = concentration 
of drug (µg/ml), m = gradient and c = intercept. A standard 
calibration graph of crude extract (fig. 1) was plotted between 
absorbance and concentration using the computer interface [18].
In vitro dissolution studies 
The dissolution profile of crude extract and optimized o
lyophilized cake were determined in a dissolution tester (Veego, 
India). All tests were conducted in 900 ml of 0.1N HCl and phosphate 
buffer medium, pH 6.8 maintained at 37±0.5 °C with a paddle 
rotation speed at 100 rpm. After specified time intervals 
40, 50, and 60 min), 5 ml samples from the dissolution medium were 
withdrawn with the help of a pipette and 5 ml of fresh medium was 
added quickly again in the dissolution medium. Then, the withdrawn 
sample was filtered and assayed for drug co
spectrophotometer at 216.9 nm wavelength (Hitachi U
spectrophotometer, Japan). The percentage of drug dissolved from 
the preparations was calculated using calibration equations [19]
In vitro release studies using dialysis bag 
In vitro release of lyophilized cake and crude extract solution was 
studied using a dialysis bag (molecular weight cut off [MWCO] 
kDa, Spectrum Medical Industries Inc) in both 0.1
phosphate buffer, pH 6.8 maintained at 37±0.5
rotation speed at 100 rpm. 2 ml of 500 mg/ml
freeze-dried cake and the same concentrated 2
were taken into the separate dialysis bag. The o
dialysis bag was tightly bound with threads. The 
placed inside the basket of the dissolution machine. Sampling was 
done by withdrawing 5 ml from the released medium with the help 
of a pipette and 5 ml of fresh medium was added quickly
Withdrawn samples were analyzed using a UV spectrophotometer at 
219.6 nm wavelength. With the help of the standard curve prepared 
earlier, drug concentration was measured [20]. 
 
Fig. 2: Effect of AETC fruits on the hole board test model
difference between groups was analyzed by one
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FTIR analysis 
The dried powder of oral lyophilized cake was diluted with potassium 
bromide in the ratio of 1:100 and the spectrum was recorded 
IR region, 2-20 µm in IRPrestige
Spectrophotometer using the diffuse reflectance accessory
Stability analysis of formulation
Stability studies of the formulated oral lyophilized cake were carried out 
by storing the formulations at three different temperatures
refrigerated condition (2-8 °C), room temperature (25
elevated temperature (40±2 °C)
formulations were evaluated visually for its appearance
and drug content. 
CNS depression activity test of formulation
The developed oral lyophilized cake (F
hole cross and hole board model with 
weight on mice to evaluate CNS depression activity.
RESULTS  
Hole board test of crude extract 
In the hole board test, the propensity of head dips significantly 
(p<0.001) lessened in the mice treated with crude extract at the 
dose of 100, 150, 200, and 400
group (fig. 2). The analogous effect was found i
diazepam (1 mg/kg).  
Hole cross test of crude extract 
We noticed that the hole cross activity significantly (p
abridged by second (30 min) and continued to sixth (150 min) 
observation period in comparison
The number of hole cross lessen
demonstrated for the fourth (90 min), fifth (120 min)
min) observation period at 200 mg/kg body weight. Also, the 
positive control group (diazepam 1 mg/kg) decrement showed a 
similar modification to that observed with 
Thiopental sodium-induced sleeping time test
In the thiopental sodium-induced sleeping time test, the 
sleep significantly (p<0.05) decreased (
sleeping time significantly (p<
manner in mice treated with crude extract at 100, 150, 200
mg/kg when compared with the control group (
, all values are expressed as the mean±standard deviation of the mean (SDM), n=
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Fig. 3: Effect of AETC fruits on hole cross test model
difference between groups was analyzed by one
Fig. 4: Time to induce sleep on thiopental sodium induced sleeping time test
the mean (SDM), n=5. The difference between groups was analyzed by one
Fig. 5: Duration of sleep produced by AETC fruits on 
mean (SDM), n=5. The difference between groups was analyzed by one
Acute toxicity test 
In the oral acute toxicity test, the highest dose (3,000 mg/kg 
weight of mice) of the fruit extract did not reveal any mortality and 
adverse effects. 
Human equivalent dose (HED) 
According to FDA,  
HED in mg/kg =  Animal Dose (mg/kg)  
× (Animal Km/Human Km
=16.22 mg/kg 
The total dose optimized for a normal, healthy individual is (16.22 × 
60) = 973.2 mg. So, 1000 mg/60 kg human equivalent dose for CNS 
depression activity was used for formulation development.
Different formulations of an oral lyophilized cake 
Different formulations (F1, F2, F3, and F4) were 
various percentages (% w/v) of mannitol, sorbitol, lactose
aspartame to formulate oral lyophilized cake
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structure of mannitol gained after freeze
required hardness and elegance of the lyophilized cake
reason, the concentration of mannitol was increased to prepare 
different formulations. The res
porous and fluffy and the original starting volume was maintained. 
This increased the surface area
Appearance and residual humidity analysis
It was found that the resulting formulation F
with incorrect appearance. F4 formulation with 
of mannitol (6 % w/v) and a lower percentage of sorbitol 
contributed no break or split
formulation with elegant cake
formulations was within acceptable specifications
Drug content of the oral cake
The drug content of the oral cake at various % w/v of the extract 
was determined using the calibration curve. 
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Drug content was 
 
In vitro dissolution studies 
The formulated cake showed greater drug dissolution compared to 
crude extract (fig. 6).  
 
Table 3: The appearance, broken units
Tests  F1 
*RH%  1.67±0.30 
Broken unit 4 
Visual aspect Fluffy 
*All values are expressed as the mean±standard deviation of the mean (SDM), n=3.
 








The formulation reveals all essential peaks of extract
no drug-excipient interaction, as shown in fig. 8
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*All values are expressed as the mean±standard deviation of the mean (SDM), n=3.
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In vitro release studies using dialysis bag
Faster drug release was observed for lyophilized oral cake 
drug release profile which is depicted






Table 4: Drug content of the oral cake 





Fig. 6: In vitro dissolution studies 
 
 7: In vitro drug release profile using dialysis bag 
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Stability analysis of F4 formulation
Stability analysis complying with 
product stability (table 5). 
Table 5: Stability analysis of F4 formulation 
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Hole board test of F4 formulation 
The lyophilized product was also evaluated for CNS activity through 
the hole board test at the dose of only 200 mg/kg body weight. In 
the hole-board test, the propensity of head dips significantly 
(p<0.001) lessened in a time-dependent manner in the mice treated 
with developed formulation at the dose of 200 mg/kg while 
compared with the control group (fig. 9).  
Hole cross test of F4 formulation 
In the case of developed formulation, the number of hole crosses 
decreased significantly (p<0.001) in the second (30 min), third (60 
min), fourth (90 min), fifth (120 min), and sixth (150 min) 
observation period at 200 mg/kg body weight (fig. 10). 
DISCUSSION 
Medicinal plants contribute to the major constituents of indigenous 
medicines. Thus, the quality and effectiveness of indigenous 
medicinal preparations depend solely on the genuineness and 
quality of the medicinal plants or products that are used in their 
preparation. So it is very important to ensure that these medicinal 
plants or their products possess the claimed properties and exert 
the desired therapeutic effects. 
The freshly prepared extract was subjected to evaluate CNS 
depression activity. The extract showed significant CNS 
depressant effect in the hole board and hole cross tests in 
comparison to control in a dose-dependent manner. In the hole 
board test, the head-dipping behavior of the animals is directly 
related to their emotional state [22]. Present finding of the hole 
board test revealed that the extract caused a dose-dependent 
reduction in head-dip response in the mice from 2nd observation of 
the experiment and lasted to the final, suggesting that the extract 
possesses sedative activity (fig. 2). In hole cross test, agents with 
sedative activity will cause a reduction in the number of 
movements and interruption in the curiosity of the new 
environment [23]. In the present study, the oral administration of 
test extract at the doses 100, 150, 200, and 400 mg/kg caused a 
marked decline in the number of hole crosses and lethargy to a 
new environment (fig. 3). The suppression effect was found at 
30 min and continued up to 150 min after administration of the 
extract. All tested doses twisted significant inhibition of 
locomotion. The suppression of locomotors by inducing crude 
extract referred to its potentiality to depress the central nervous 
system. Present findings of CNS depressant activity were further 
supported by the results observed in the thiopental sodium-
induced sleeping time determination test (fig. 4 and fig. 5). This 
test is a classical method in behavioral pharmacology to 
investigate the sedative and hypnotic properties of medicinal plant 
extract [24]. In the present study, different doses of the extract 
significantly decreased the latency to induce sleep while increased 
the duration of hypnosis induced by thiopental sodium. As 
expected, similar types of effects were observed by the 
administration with diazepam used as standard. 
Spontaneous locomotor activity is considered as an index of 
attentiveness and can be helpful to corroborate the general depressive 
activity of any drug. The decrease in motor activity gives a hint of the 
level of excitability of the CNS and this decrease may be related to 
sedation resulting from depression of the CNS. It is reported that GABA, 
an inhibitory neurotransmitter, is involved in the pathophysiology of 
depression [25]. The extract may act by potentiating GABAergic 
inhibition in the CNS by membrane hyperpolarization, which diminishes 
the firing rate of vital neurons in the brain [26]. The sedation may also be 
due to improved affinity for GABA or a boost in the duration of the 
GABA-gated channel opening [27]. 
Literature reviews confirmed the presence of alkaloids, glycosides, 
flavonoids, carbohydrates, saponins, steroids, and tannins in the 
crude extract of Terminalia chebula fruits [6]. There are several 
reports which demonstrated that the alkaloids, glycosides, and 
flavonoids rich plant and plant extracts possess sedative property 
mediated through their affinity (in vitro) with benzodiazepine site of 
GABAergic complex system or are direct or indirect modulators of 
this receptor [28, 29]. Datta et al., 2004 [30] described that the 
flavonol glycoside quercetin-3-O-(6″-feruloyl)-β-D-galacto-
pyranoside, isolated from the aerial parts of Polygonum viscosum 
presented CNS depressant activity. Rutin is a glycoside derivative 
that exerted a significant CNS depression activity at 10 mg/kg [31]. 
Both the quercetin and rutin were found to be present in Terminalia 
chebula [32]. Besides, nonspecific CNS depression can also be 
attributed to tannin [33]. Therefore, it appears that the above-
mentioned phytochemicals present in the extract may contribute to 
the sedative effects on the CNS. 
The experimental screening method is imperative to establish the 
safety and efficacy of traditional and herbal products and also to set 
up the active components of the herbal products. In the acute 
toxicity test of the extract, there was no mortality or any signs of 
behavioral changes or toxicity observed after oral administration of 
extract up to the dose level of 3000 mg/kg body weight in mice. The 
results of the present study have shown that acute administration of 
extract may be safe up to 3000 mg/kg body weight. 
The oral lyophilized cake can be considered as an interesting fast 
dissolving oral dosage form [17]. Fast dissolving lyophilized cakes 
offer the combined advantages of performance, convenience [16], 
rapid onset of action, patient compliance, and allow administration of 
an oral solid dosage form in the absence of water or fluid intake [34]. 
F4 has been selected as the best formula among four formulations 
which has a crystalline structure containing an elegant cake. The 
prepared oral lyophilized cake was evaluated for various 
pharmaceutical parameters and results were mentioned in table 3. 
According to the results, it is evident that the formulated lyophilized 
cake showed good physicochemical properties. When placed on the 
tongue, lyophilized cake disintegrates instantaneously, releasing the 
drug, which dissolves or disperses in the saliva [35]. The formulation 
exhibited fast dissolution of drugs depicted in fig. 6 and 7. All essential 
peaks of the extract obtained from the FTIR imaging of the formulation 
ensure no drug-excipient interaction as shown in fig. 8. 
 
 
Fig. 8: Combined FT-IR 
Fig. 9: Effect of AETC fruits from oral lyophiliz
mean (SDM), n=5. The difference between groups was analyzed by one
Fig. 10: Effect of AETC fruits from oral lyophiliz
mean (SDM), n=5. The difference between groups was analyzed by one
 
The lyophilized product was also evaluated for CNS activity through 
the hole board and hole cross tests at the dose of only 200 mg/kg 
body weight. There were no significant differences in the CNS 
activities in both methods. In the hole board method, the nu
head dipping (fig. 9) by mice using crude extract and 
cake was about to equal. On the other hand, in hole cross test
10) almost similar result was found in the case of crude extract and 
formulated cake. According to CNS result and FTIR analysis, it can be 
ensured that active ingredients of crude extract were as usual 
the formulated product. 
CONCLUSION 
The present study revealed that rapid dissolving
aqueous lyophilized cake of Terminalia chebula 
to benefit in the health care sector due to its
depression activity. As per ICH guidelines, the stability analysis 
ensures the stability of newly formulated herbal 
typical F4 formulation was found to have all the desirable properties. 
The effect is rapid, long-lasting, and statistically significant at
experimental doses tested. However, further studies are needed to 
isolate the bioactive compound(s) and explicate 
mechanisms in order to establish a safe and effective dosage.
Furthermore, it is required to verify the possibility of its use in the 
prevention and treatment of neurological disorders
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